» Articles » PMID: 28106331

A Randomized Controlled Trial of Fresh Frozen Plasma for Coagulopathy in Russell's Viper (Daboia Russelii) Envenoming

Overview
Publisher Elsevier
Specialty Hematology
Date 2017 Jan 21
PMID 28106331
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Summary: Background Russell's viper (Daboia russelii) envenoming is a major health issue in South Asia and causes venom-induced consumption coagulopathy (VICC). Objectives To investigate the effects of fresh frozen plasma (FFP) and two antivenom doses in correcting VICC. Methods We undertook an open-label randomized controlled trial in patients with VICC at two Sri Lankan hospitals. Patients with suspected Russell's viper bites and coagulopathy were randomly allocated (1 : 1) to high-dose antivenom (20 vials) or low-dose antivenom (10 vials) plus 4 U of FFP. The primary outcome was the proportion of patients with an International Normalized Ratio (INR) of < 2 at 6 h after antivenom administration. Secondary outcomes included anaphylaxis, major hemorrhage, death, and clotting factor recovery. Results From 214 eligible patients, 141 were randomized: 71 to high-dose antivenom, and 70 to low-dose antivenom/FFP; five had no post-antivenom blood tests. The groups were similar except for a delay of 1 h in antivenom administration for FFP patients. Six hours after antivenom administration, 23 of 69 (33%) patients allocated to high-dose antivenom had an INR of < 2, as compared with 28 of 67 (42%) allocated to low-dose antivenom/FFP (absolute difference 8%; 95% confidence interval - 8% to 25%). Fifteen patients allocated to FFP did not receive it. Severe anaphylaxis occurred equally frequently in each group. One patient given FFP developed transfusion-related acute lung injury. Three deaths occurred in low-dose antivenom/FFP patients, including one intracranial hemorrhage. There was no difference in recovery rates of INR or fibrinogen, but there was more rapid initial recovery of factor V and FX in FFP patients. Conclusion FFP after antivenom administration in patients with Russell's viper bites did not hasten recovery of coagulopathy. Low-dose antivenom/FFP did not worsen VICC, suggesting that low-dose antivenom is sufficient.

Citing Articles

Clinical Characteristics of Snakebite Envenomings in Taiwan.

Mao Y, Liu P, Lai K, Luo Y, Chen K, Lai C Toxins (Basel). 2025; 17(1).

PMID: 39852967 PMC: 11769513. DOI: 10.3390/toxins17010014.


Treatment response and clinical features of snakebite envenomation in Alborz province, Iran: A cross-sectional study.

Farajidana H, Mosalamiaghili S, Assadian K, Jahangiri S, Masumzadegan M, Sadeghi F Health Sci Rep. 2024; 7(10):e70135.

PMID: 39416345 PMC: 11480123. DOI: 10.1002/hsr2.70135.


The Chinese guideline for management of snakebites.

Lai R, Yan S, Wang S, Yang S, Yan Z, Lan P World J Emerg Med. 2024; 15(5):333-355.

PMID: 39290598 PMC: 11402871. DOI: 10.5847/wjem.j.1920-8642.2024.076.


[A global core outcome measurement set for snakebite clinical trials].

Abouyannis M, Esmail H, Hamaluba M, Ngama M, Mwangudzah H, Mumba N Med Trop Sante Int. 2023; 3(3).

PMID: 38094484 PMC: 10714599. DOI: 10.48327/mtsi.v3i3.2023.421.


Associated Clinical Factors for Coagulation Dysfunction due to : A Retrospective Observational Study.

Xie R, Ye X, Tang C, Wang Y, Zhong L J Toxicol. 2023; 2023:8832355.

PMID: 37168533 PMC: 10164868. DOI: 10.1155/2023/8832355.


References
1.
OLeary M, Isbister G . Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy. Toxicon. 2013; 77:125-32. DOI: 10.1016/j.toxicon.2013.11.001. View

2.
Kularatne S, Silva A, Weerakoon K, Maduwage K, Walathara C, Paranagama R . Revisiting Russell's viper (Daboia russelii) bite in Sri Lanka: is abdominal pain an early feature of systemic envenoming?. PLoS One. 2014; 9(2):e90198. PMC: 3936006. DOI: 10.1371/journal.pone.0090198. View

3.
Lalloo D, Trevett A, Korinhona A, Nwokolo N, Laurenson I, Paul M . Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am J Trop Med Hyg. 1995; 52(6):525-31. DOI: 10.4269/ajtmh.1995.52.525. View

4.
Ferguson L, Morling A, Moraes C, Baker R . Investigation of coagulopathy in three cases of tiger snake (Notechis ater occidentalis) envenomation. Pathology. 2002; 34(2):157-61. DOI: 10.1080/003130201201117172. View

5.
Viravan C, Looareesuwan S, Kosakarn W, Wuthiekanun V, McCarthy C, Stimson A . A national hospital-based survey of snakes responsible for bites in Thailand. Trans R Soc Trop Med Hyg. 1992; 86(1):100-6. DOI: 10.1016/0035-9203(92)90463-m. View